Connexon Creative Launches Extracellular Matrix News - April 22, 2010
Extracellular Matrix News compiles all of the newest and hottest research in the field of extracellular matrix biology.

Connexon Creative Launches Pancreatic Cell News - April 20, 2010
E-newsletter focuses on the latest information in the pancreatic cell community.

Connexon Creative Launches Prostate Cell News - January 15, 2010
Connexon Creative Inc. is pleased to announce the launch of its 8th online publication, Prostate Cell News.

Connexon Creative Launches Hematopoiesis News - January 12, 2010
E-newsletter focuses on the latest information in the hematopoietic field.

Connexon Creative Launches Immune Regulation News - October 9, 2009
Immune Regulation News will be released every Friday and allows researchers, clinicians and industry professionals to remain current in the field of immunology.

Connexon Creative Launches Mesenchymal Cell News - October 1, 2009
The goal of Mesenchymal Cell News is to facilitate communication of scientific information between members of the mesenchymal cell community on a weekly basis.

Connexon Creative Launches Cord Blood News - June 18, 2009
E-newsletter focuses on the latest information in the cord blood industry.

Connexon Creative Launches Mammary Cell News - May 14, 2009
Mammary Cell News highlights research in the fields of breast cancer, mammary gland biology, mammary stem cells, breast cancer clinical trials and much more.

Connexon Creative Launches Neural Cell News - March 1, 2008
Connexon Creative Inc. is pleased to announce the launch of its 3rd online publication, Neural Cell News.

Connexon Creative Launches Embryonic Stem Cell News - August 22, 2007
A weekly e-newsletter, with emphasis on embryonic and induced pluripotent stem cell research.

Connexon Creative Inc. Launches New Corporate Website - May 10, 2007
Website focuses on delivering resources that power communication in science and medicine.

Connexon Creative Launches its First Publication: Cell Therapy News - February 1, 2002
E-newsletter focuses on the latest information affecting cellular therapies.